BiliaryTractCancer near Largo, FL

Care Philosophy: Patrick Hwu, MD, is the president and CEO of Moffitt Cancer Center, one of the nation's leading cancer hospitals and the only National Cancer Institute-designated comprehensive cancer center based in Florida. As an internationally recognized tumor immunologist, Dr Hwu has led pioneering research and clinical efforts to better understand the interactions between tumors and the immune system. He helped launch the field of gene-modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Castaneda Puglianini earned his MD from Universidad Peruana Cayetano Heredia in Lima, Peru, and completed an Internal Medicine residency at Albert Einstein College of Medicine in New York. He completed a Hematology/Oncology fellowship at Virginia Commonwealth University/Massey Cancer Center followed by a Blood and Marrow Transplantation and Cellular Immunotherapy fellowship at Moffitt Cancer Center. Dr Castaneda Puglianini joins us from Virginia Commonwealth University where he was an Assistant Professor of Medicine and served as Director, CAR T-Cell Therapy Program in the Division of Hematology/Oncology and Palliative Care at VCU Massey Cancer Center.

Care Philosophy: Dr Michael Nieder is a Senior Member of the Blood and Marrow Transplant Department at Moffitt Cancer Center and Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. He is also the Blood and Marrow Transplant Program Fellowship Director and the Inpatient Medical Director. Dr Nieder's research interests include toxicity reduction and supportive care improvements for patients undergoing transplantation. Dr Nieder is currently studying the intestinal microbiome in patients undergoing blood and marrow transplantation and is Principle Investigator of a nationally funded trial using probiotics in patients undergoing allogeneic transplantation.

Care Philosophy: Dr Kosj Yamoah is Chair in the Department of Radiation Oncology with a secondary appointment in the Cancer Epidemiology Program at Moffitt Cancer Center. Dr Yamoah's clinical focus is genitourinary malignancies. He currently serves as the Section Head for Genitourinary Radiation Oncology and Director for Radiation Oncology Health Disparities Research. He is committed to increasing access and quality of care among the minority population, particularly men of African descent. His clinical expertise focuses on prostate cancer, prostate brachytherapy, intensity- modulation radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Lazaryan completed his post-graduate medical training in Internal Medicine and Hematology/Medical Oncology at the Cleveland Clinic Foundation, Ohio followed by the faculty appointment in Blood and Marrow Transplantation and hematological malignancies at the University of Minnesota. He also obtained Masters and PhD in Public Health from the State University of NY at Albany and University of Alabama in Birmingham, respectively. Since joining Moffitt in 2018, Dr Lazaryan has been focusing his clinical and research expertise in managing complex patients with lymphoma who are in need for BMT and/or cellular immunotherapy such as CAR T cell therapy.